Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2012; 18(2): 150-155
Published online Jan 14, 2012. doi: 10.3748/wjg.v18.i2.150
Published online Jan 14, 2012. doi: 10.3748/wjg.v18.i2.150
Table 1 Characteristics of patients with gastric cancer
| Clinicopathological feature | Frequency n (%) | |
| Patient age at diagnosis (yr) | Mean 69.6, min-max 27-96 | |
| Tumor diameter (cm) | Mean 4.6, min-max 1.3-12 | |
| Gender | Male | 84 (70) |
| Female | 36 (30) | |
| Histological type | Intestinal | 80 (66.66) |
| Diffuse | 24 (20) | |
| Mixed | 16 (13.33) | |
| Tumor location | Cardia | 37 (30.8) |
| Corpus | 39 (32.5) | |
| Antrum | 44 (36.66) | |
| pT stage | pT1 | 15 (12.5) |
| pT2 | 65 (54.16) | |
| pT3-4 | 40 (33.33) | |
| pN stage | pN0 | 36 (30) |
| pN1 | 43 (35.8) | |
| pN2+3 | 41 (34.2) | |
| pM stage | pM0 | 105 (87.5) |
| pM1 | 15 (12.5) | |
| Tumor grade | G1-2 | 42 (35) |
| G3 | 78 (65) | |
| Venous invasion | Present | 37 (30.8) |
| Absent | 83 (69.2) | |
| Lymphatic invasion | Present | 84 (70) |
| Absent | 36 (30) | |
| Adjuvant therapy | None | 32 (26.6) |
| Treated | 88 (73.4) | |
| Chemotherapy | 55 (62.5) | |
| Chemo/Radiotherapy | 33 (37.5) | |
| 5-year survival (%) | (95% CI) | 38.9 (25-52) |
- Citation: Tsapralis D, Panayiotides I, Peros G, Liakakos T, Karamitopoulou E. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology. World J Gastroenterol 2012; 18(2): 150-155
- URL: https://www.wjgnet.com/1007-9327/full/v18/i2/150.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i2.150